Anzeige
Erschienen in:
01.08.2016 | Short Communication
Age at First Rotavirus Vaccination and Risk of Intussusception in Infants: A Public Health Modeling Analysis
Erschienen in: Drug Safety | Ausgabe 8/2016
Einloggen, um Zugang zu erhaltenAbstract
Introduction
The epidemiology of naturally occurring intussusception is known to increase significantly between the ages of 3 and 8 months. Post-licensure studies have reported a fivefold and twofold increase in intussusception in the first week after the first dose and second dose, respectively, of current rotavirus vaccines (RVs).
Purpose
We carried out a public health risk analysis to model the impact of age at first vaccination in relation to rotavirus vaccination and risk of intussusception in infants.
Method
We created a static model for a birth cohort followed until 1 year old to estimate the number of excess intussusception hospitalizations which could be caused by three different infant rotavirus vaccination schedules. A relative risk of 5.45 in the first 7 days after the first dose and 1.75 in the first 7 days after the second dose was used in the model.
Result
We estimated that the risk of intussusception would be the lowest at about 1 in 49,000 if both first and second dose RVs were given at <3 months of age followed by 1 in 41,000 if first dose RVs were given at <3 months and second dose RVs were given at 3–5 months. It would be highest at about 1 in 11,000 if infants received both doses when >3 months old.
Conclusion
Our epidemiological example illustrates the importance of ensuring that the first two doses of RVs are administered in infants <3 months old whenever possible to minimize the risk of intussusception as an adverse event following rotavirus vaccination.